# Chronic Lymphocytic Leukemia Research

{
  "id": "T11157",
  "title": "Chronic Lymphocytic Leukemia Research",
  "url": "/topics/T11157",
  "kind": "topic-directory",
  "aeo_cohort": "topic-directory",
  "provider": "openalex",
  "revision": "f45b2e1a714e82bf",
  "catalogue_revision": "f050b5d4780b1289",
  "numeric_address": "36240765467127082",
  "address_version": "morton4x16-v1",
  "coordinates": [
    4,
    27,
    2716,
    11157
  ],
  "answer_status": "Directory metadata; local answer requires separate source review",
  "truth_status": "Subject descriptor, not a factual answer or a demonstrated knowledge gap"
}

This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.

Directory metadata is not a factual answer or evidence of a global knowledge gap.

Source: https://openalex.org/T11157

No owner-reviewed local answer yet.